Use of andexanet alfa: A British Society for Haematology position statement.

Buka RJ., Arachchillage DJ., Bagot CN., Benson G., Bradbury CA., Curry N., Hunt BJ., Sutton DJ., Thomas MR., Westwood JP., Breen K.

DOI

10.1111/bjh.70509

Type

Journal article

Publication Date

2026-04-25T00:00:00+00:00

Keywords

andexanet alfa, direct factor‐Xa inhibitor, direct oral anticoagulants

Permalink More information Close